Public Profile

Covidien Belgium BVBA

Covidien Belgium BVBA, a prominent player in the medical device industry, is headquartered in Belgium and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in innovative healthcare solutions, focusing on areas such as surgical devices, respiratory care, and vascular therapies. With a commitment to quality and safety, Covidien Belgium BVBA offers a diverse range of core products, including advanced surgical instruments and critical care equipment, which are designed to enhance patient outcomes. The company is recognised for its cutting-edge technology and dedication to research and development, positioning it as a trusted partner in the healthcare sector. Notable achievements include significant contributions to minimally invasive procedures, solidifying its market position as a key provider of medical solutions that improve efficiency and effectiveness in clinical settings.

DitchCarbon Score

DitchCarbon Score

How does Covidien Belgium BVBA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Covidien Belgium BVBA's score of is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Covidien Belgium BVBA's reported carbon emissions

Covidien Belgium BVBA, headquartered in Belgium, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the healthcare sector are increasingly focusing on sustainability and reducing their carbon footprints. This trend often includes setting science-based targets and committing to various climate initiatives. However, without specific information from Covidien Belgium BVBA, it is challenging to provide a detailed overview of their climate commitments or emissions performance.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Covidien Belgium BVBA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Covidien Belgium BVBA is in BE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Covidien Belgium BVBA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers